nodes	percent_of_prediction	percent_of_DWPC	metapath
Econazole—CYP17A1—Dexamethasone—psoriasis	0.234	0.296	CbGbCtD
Econazole—CYP19A1—Betamethasone—psoriasis	0.156	0.198	CbGbCtD
Econazole—CYP19A1—Dexamethasone—psoriasis	0.091	0.115	CbGbCtD
Econazole—CYP3A4—Calcitriol—psoriasis	0.0517	0.0655	CbGbCtD
Econazole—CYP3A4—Methoxsalen—psoriasis	0.0402	0.051	CbGbCtD
Econazole—CYP2E1—Dexamethasone—psoriasis	0.038	0.0482	CbGbCtD
Econazole—CYP3A4—Cholecalciferol—psoriasis	0.0266	0.0338	CbGbCtD
Econazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.0231	0.0293	CbGbCtD
Econazole—CYP3A4—Triamcinolone—psoriasis	0.0231	0.0293	CbGbCtD
Econazole—CYP3A4—Betamethasone—psoriasis	0.0198	0.0251	CbGbCtD
Econazole—CYP3A4—Prednisolone—psoriasis	0.0196	0.0248	CbGbCtD
Econazole—CYP3A4—Hydrocortisone—psoriasis	0.0185	0.0235	CbGbCtD
Econazole—CYP3A4—Prednisone—psoriasis	0.0185	0.0234	CbGbCtD
Econazole—CYP3A4—Cyclosporine—psoriasis	0.0175	0.0222	CbGbCtD
Econazole—Stinging—Calcipotriol—psoriasis	0.0169	0.104	CcSEcCtD
Econazole—Burning sensation—Tazarotene—psoriasis	0.0146	0.0892	CcSEcCtD
Econazole—Stinging—Tazarotene—psoriasis	0.0125	0.0765	CcSEcCtD
Econazole—CYP3A4—Dexamethasone—psoriasis	0.0115	0.0146	CbGbCtD
Econazole—Stinging—Clobetasol propionate—psoriasis	0.0106	0.0648	CcSEcCtD
Econazole—Erythema—Calcipotriol—psoriasis	0.006	0.0367	CcSEcCtD
Econazole—Prurigo—Hydrocortisone—psoriasis	0.00496	0.0304	CcSEcCtD
Econazole—Erythema—Tazarotene—psoriasis	0.00442	0.0271	CcSEcCtD
Econazole—Pain—Calcipotriol—psoriasis	0.00419	0.0256	CcSEcCtD
Econazole—Erythema—Clobetasol propionate—psoriasis	0.00375	0.023	CcSEcCtD
Econazole—Burning sensation—Cyclosporine—psoriasis	0.00371	0.0227	CcSEcCtD
Econazole—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.0035	0.0756	CbGpPWpGaD
Econazole—Pruritus—Calcipotriol—psoriasis	0.00346	0.0212	CcSEcCtD
Econazole—Erythema—Fluocinonide—psoriasis	0.00338	0.0207	CcSEcCtD
Econazole—Stinging—Cyclosporine—psoriasis	0.00318	0.0195	CcSEcCtD
Econazole—Pain—Tazarotene—psoriasis	0.00309	0.0189	CcSEcCtD
Econazole—Stinging—Prednisolone—psoriasis	0.00289	0.0177	CcSEcCtD
Econazole—Stinging—Hydrocortisone—psoriasis	0.00283	0.0173	CcSEcCtD
Econazole—CYP51A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00278	0.06	CbGpPWpGaD
Econazole—CYP51A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00274	0.0592	CbGpPWpGaD
Econazole—Erythema—Methoxsalen—psoriasis	0.00267	0.0163	CcSEcCtD
Econazole—Stinging—Triamcinolone—psoriasis	0.00266	0.0163	CcSEcCtD
Econazole—Pain—Clobetasol propionate—psoriasis	0.00262	0.016	CcSEcCtD
Econazole—Pruritus—Tazarotene—psoriasis	0.00255	0.0156	CcSEcCtD
Econazole—Stinging—Dexamethasone—psoriasis	0.00241	0.0148	CcSEcCtD
Econazole—Stinging—Betamethasone—psoriasis	0.00241	0.0148	CcSEcCtD
Econazole—Pain—Beclomethasone—psoriasis	0.00238	0.0146	CcSEcCtD
Econazole—Erythema—Calcitriol—psoriasis	0.00238	0.0146	CcSEcCtD
Econazole—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00236	0.051	CbGpPWpGaD
Econazole—Pain—Fluocinonide—psoriasis	0.00236	0.0145	CcSEcCtD
Econazole—CYP17A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00233	0.0504	CbGpPWpGaD
Econazole—CYP51A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00225	0.0487	CbGpPWpGaD
Econazole—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00217	0.0468	CbGpPWpGaD
Econazole—Pruritus—Clobetasol propionate—psoriasis	0.00217	0.0133	CcSEcCtD
Econazole—Erythema—Acitretin—psoriasis	0.00212	0.013	CcSEcCtD
Econazole—Erythema—Fluocinolone Acetonide—psoriasis	0.00211	0.0129	CcSEcCtD
Econazole—Burning sensation—Methotrexate—psoriasis	0.00205	0.0125	CcSEcCtD
Econazole—Pruritus—Fluocinonide—psoriasis	0.00195	0.012	CcSEcCtD
Econazole—CYP17A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00191	0.0414	CbGpPWpGaD
Econazole—CYP51A1—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.00188	0.0405	CbGpPWpGaD
Econazole—Erythema—Hydroxyurea—psoriasis	0.00166	0.0102	CcSEcCtD
Econazole—Pain—Calcitriol—psoriasis	0.00166	0.0102	CcSEcCtD
Econazole—Pruritus—Methoxsalen—psoriasis	0.00154	0.00944	CcSEcCtD
Econazole—CYP51A1—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.0015	0.0324	CbGpPWpGaD
Econazole—Pain—Acitretin—psoriasis	0.00148	0.00905	CcSEcCtD
Econazole—Pain—Fluocinolone Acetonide—psoriasis	0.00147	0.00902	CcSEcCtD
Econazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00143	0.0309	CbGpPWpGaD
Econazole—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00141	0.0305	CbGpPWpGaD
Econazole—Pruritus—Calcitriol—psoriasis	0.00137	0.00841	CcSEcCtD
Econazole—Pruritus—Acitretin—psoriasis	0.00122	0.00748	CcSEcCtD
Econazole—Miconazole—NOS2—psoriasis	0.00122	1	CrCbGaD
Econazole—Pruritus—Fluocinolone Acetonide—psoriasis	0.00122	0.00746	CcSEcCtD
Econazole—CYP51A1—Biological oxidations—CYP2S1—psoriasis	0.0012	0.0258	CbGpPWpGaD
Econazole—CYP51A1—Metapathway biotransformation—CYP2S1—psoriasis	0.00118	0.0255	CbGpPWpGaD
Econazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00116	0.0251	CbGpPWpGaD
Econazole—Pain—Hydroxyurea—psoriasis	0.00116	0.0071	CcSEcCtD
Econazole—Erythema—Prednisolone—psoriasis	0.00102	0.00627	CcSEcCtD
Econazole—CYP17A1—Biological oxidations—CYP2S1—psoriasis	0.00102	0.022	CbGpPWpGaD
Econazole—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00101	0.0217	CbGpPWpGaD
Econazole—CYP17A1—Metapathway biotransformation—CYP2S1—psoriasis	0.001	0.0217	CbGpPWpGaD
Econazole—Erythema—Hydrocortisone—psoriasis	0.001	0.00613	CcSEcCtD
Econazole—Pain—Mycophenolic acid—psoriasis	0.000971	0.00595	CcSEcCtD
Econazole—Erythema—Triamcinolone—psoriasis	0.000942	0.00577	CcSEcCtD
Econazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.0009	0.0194	CbGpPWpGaD
Econazole—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000888	0.0192	CbGpPWpGaD
Econazole—Erythema—Betamethasone—psoriasis	0.000855	0.00524	CcSEcCtD
Econazole—Erythema—Dexamethasone—psoriasis	0.000855	0.00524	CcSEcCtD
Econazole—Pruritus—Mycophenolic acid—psoriasis	0.000804	0.00492	CcSEcCtD
Econazole—Pain—Cyclosporine—psoriasis	0.000786	0.00481	CcSEcCtD
Econazole—Pain—Mycophenolate mofetil—psoriasis	0.000767	0.00469	CcSEcCtD
Econazole—Erythema—Prednisone—psoriasis	0.000745	0.00456	CcSEcCtD
Econazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00073	0.0158	CbGpPWpGaD
Econazole—Pain—Prednisolone—psoriasis	0.000715	0.00438	CcSEcCtD
Econazole—Pain—Hydrocortisone—psoriasis	0.000698	0.00428	CcSEcCtD
Econazole—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	0.00069	0.0149	CbGpPWpGaD
Econazole—Pain—Triamcinolone—psoriasis	0.000658	0.00403	CcSEcCtD
Econazole—Pruritus—Cyclosporine—psoriasis	0.00065	0.00398	CcSEcCtD
Econazole—Pruritus—Mycophenolate mofetil—psoriasis	0.000634	0.00388	CcSEcCtD
Econazole—Erythema—Methotrexate—psoriasis	0.000622	0.00381	CcSEcCtD
Econazole—CYP19A1—Biological oxidations—CYP2S1—psoriasis	0.000616	0.0133	CbGpPWpGaD
Econazole—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000608	0.0131	CbGpPWpGaD
Econazole—Pain—Dexamethasone—psoriasis	0.000597	0.00365	CcSEcCtD
Econazole—Pain—Betamethasone—psoriasis	0.000597	0.00365	CcSEcCtD
Econazole—Pruritus—Hydrocortisone—psoriasis	0.000578	0.00354	CcSEcCtD
Econazole—Pruritus—Triamcinolone—psoriasis	0.000544	0.00333	CcSEcCtD
Econazole—CYP19A1—Tryptophan metabolism—CAT—psoriasis	0.000532	0.0115	CbGpPWpGaD
Econazole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000518	0.0112	CbGpPWpGaD
Econazole—CYP51A1—SREBP signalling—PPARG—psoriasis	0.000505	0.0109	CbGpPWpGaD
Econazole—Pruritus—Betamethasone—psoriasis	0.000494	0.00302	CcSEcCtD
Econazole—Pruritus—Dexamethasone—psoriasis	0.000494	0.00302	CcSEcCtD
Econazole—Pain—Methotrexate—psoriasis	0.000434	0.00266	CcSEcCtD
Econazole—Pruritus—Prednisone—psoriasis	0.00043	0.00263	CcSEcCtD
Econazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000418	0.00902	CbGpPWpGaD
Econazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000413	0.00893	CbGpPWpGaD
Econazole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000412	0.0089	CbGpPWpGaD
Econazole—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000388	0.00838	CbGpPWpGaD
Econazole—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000382	0.00826	CbGpPWpGaD
Econazole—Pruritus—Methotrexate—psoriasis	0.000359	0.0022	CcSEcCtD
Econazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000338	0.00732	CbGpPWpGaD
Econazole—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000334	0.00723	CbGpPWpGaD
Econazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000334	0.00722	CbGpPWpGaD
Econazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000288	0.00623	CbGpPWpGaD
Econazole—CYP51A1—Metabolism—NDUFA5—psoriasis	0.000241	0.0052	CbGpPWpGaD
Econazole—CYP51A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000224	0.00485	CbGpPWpGaD
Econazole—CYP17A1—Metabolism—NDUFA5—psoriasis	0.000205	0.00442	CbGpPWpGaD
Econazole—CYP51A1—Metabolism—CYP2S1—psoriasis	0.000205	0.00442	CbGpPWpGaD
Econazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000192	0.00414	CbGpPWpGaD
Econazole—CYP17A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000191	0.00412	CbGpPWpGaD
Econazole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.00018	0.00389	CbGpPWpGaD
Econazole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000177	0.00383	CbGpPWpGaD
Econazole—CYP17A1—Metabolism—CYP2S1—psoriasis	0.000174	0.00376	CbGpPWpGaD
Econazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000155	0.00335	CbGpPWpGaD
Econazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000134	0.00289	CbGpPWpGaD
Econazole—CYP19A1—Metabolism—NDUFA5—psoriasis	0.000124	0.00268	CbGpPWpGaD
Econazole—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000116	0.0025	CbGpPWpGaD
Econazole—CYP51A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000107	0.00232	CbGpPWpGaD
Econazole—CYP19A1—Metabolism—CYP2S1—psoriasis	0.000105	0.00228	CbGpPWpGaD
Econazole—CYP51A1—Metabolism—CARM1—psoriasis	9.99e-05	0.00216	CbGpPWpGaD
Econazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	9.86e-05	0.00213	CbGpPWpGaD
Econazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	9.49e-05	0.00205	CbGpPWpGaD
Econazole—CYP51A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.34e-05	0.00202	CbGpPWpGaD
Econazole—CYP17A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.11e-05	0.00197	CbGpPWpGaD
Econazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	8.61e-05	0.00186	CbGpPWpGaD
Econazole—CYP17A1—Metabolism—CARM1—psoriasis	8.49e-05	0.00184	CbGpPWpGaD
Econazole—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.94e-05	0.00172	CbGpPWpGaD
Econazole—CYP2E1—Metabolism—NDUFA5—psoriasis	7.79e-05	0.00168	CbGpPWpGaD
Econazole—CYP2E1—Metabolism—CYP2S1—psoriasis	6.63e-05	0.00143	CbGpPWpGaD
Econazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	6.51e-05	0.00141	CbGpPWpGaD
Econazole—CYP51A1—Metabolism—CAT—psoriasis	6.14e-05	0.00133	CbGpPWpGaD
Econazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.52e-05	0.00119	CbGpPWpGaD
Econazole—CYP17A1—Metabolism—CAT—psoriasis	5.22e-05	0.00113	CbGpPWpGaD
Econazole—CYP19A1—Metabolism—CARM1—psoriasis	5.15e-05	0.00111	CbGpPWpGaD
Econazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.81e-05	0.00104	CbGpPWpGaD
Econazole—CYP51A1—Metabolism—APOE—psoriasis	4.77e-05	0.00103	CbGpPWpGaD
Econazole—CYP51A1—Metabolism—PPARG—psoriasis	4.16e-05	0.000899	CbGpPWpGaD
Econazole—CYP17A1—Metabolism—APOE—psoriasis	4.06e-05	0.000877	CbGpPWpGaD
Econazole—CYP3A4—Metabolism—NDUFA5—psoriasis	3.62e-05	0.000782	CbGpPWpGaD
Econazole—CYP17A1—Metabolism—PPARG—psoriasis	3.54e-05	0.000764	CbGpPWpGaD
Econazole—CYP2E1—Metabolism—CARM1—psoriasis	3.24e-05	0.000699	CbGpPWpGaD
Econazole—CYP19A1—Metabolism—CAT—psoriasis	3.17e-05	0.000684	CbGpPWpGaD
Econazole—CYP3A4—Metabolism—CYP2S1—psoriasis	3.07e-05	0.000665	CbGpPWpGaD
Econazole—CYP19A1—Metabolism—APOE—psoriasis	2.46e-05	0.000531	CbGpPWpGaD
Econazole—CYP19A1—Metabolism—PPARG—psoriasis	2.14e-05	0.000463	CbGpPWpGaD
Econazole—CYP2E1—Metabolism—CAT—psoriasis	1.99e-05	0.00043	CbGpPWpGaD
Econazole—CYP2E1—Metabolism—APOE—psoriasis	1.55e-05	0.000334	CbGpPWpGaD
Econazole—CYP3A4—Metabolism—CARM1—psoriasis	1.5e-05	0.000325	CbGpPWpGaD
Econazole—CYP2E1—Metabolism—PPARG—psoriasis	1.35e-05	0.000291	CbGpPWpGaD
Econazole—CYP3A4—Metabolism—CAT—psoriasis	9.24e-06	0.0002	CbGpPWpGaD
Econazole—CYP3A4—Metabolism—APOE—psoriasis	7.18e-06	0.000155	CbGpPWpGaD
Econazole—CYP3A4—Metabolism—PPARG—psoriasis	6.25e-06	0.000135	CbGpPWpGaD
